Escitalopram, available under the brand names Cipralex and Lexapro, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Escitalopram is majorly used to treat a major depressive disorder or generalized anxiety disorder. It is administered by mouth. Lexapro, a prescription medicine used to treat the major depressive disorder and generalized anxiety disorder symptoms. Lexapro may be used alone or in combination with other medications.
MARKET SCOPE
The "Global Lexapro Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Lexapro market with detailed market segmentation by type, application, end use, and geography. The report provides key statistics on the market status of the leading Lexapro market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global Lexapro market is segmented into tablet, solution.
- On the basis of end use, the market is segmented into antianxiety, antidepressant, others.
- On the basis of end use, the market is segmented into hospitals, clinics, others.
MARKET DYNAMICS
Drivers:
- Rise in the incidences of mental health disorders.
- Rise in the demand for antidepressants.
- Growing geriatric population.
Restraints:
- The several risks associated with Lexapro is the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Lexapro market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Lexapro market in these regions.
IMPACT OF COVID-19ON LEXAPRO MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Lexapro market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Lexapro market are anticipated to lucrative growth opportunities in the future with the rising demand for Lexapro in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Lexapro market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Lundbeck
- Amneal Pharmaceuticals
- Forest Laboratories
- TEVA
- Mylan
- Silarx Pharmacueticals
- Apotex
- Lupin
- Novartis
- Hikma Pharmaceuticals